Dr. Joshua Tobias holds a permanent position as a senior scientist and is a project and team leader at the Medical University of Vienna. He has 20 years of experience in microbiology, molecular biology, and the construction of clinically evaluated peptide- and protein-based vaccines against infectious diseases and cancer. For the last 10 years, his work has resulted in several B-cell peptide/mimotope-based cancer vaccine candidates and several peer-reviewed original and review articles (see references).
Dr. Joshua Tobias holds a permanent position as a senior scientist and is a project and team leader at the Medical University of Vienna. He has 20 years of experience in microbiology, molecular biology, and the construction of clinically evaluated peptide- and protein-based vaccines against infectious diseases and cancer. For the last 10 years, his work has resulted in several B-cell peptide/mimotope-based cancer vaccine candidates and several peer-reviewed original and review articles (see references).